Duration and dose of antiepileptic drugs and serum calcium levels in children

Main Article Content

Arinta Atmasari
Masayu Rita Dewi
Aditiawati Aditiawati
Masagus Irsan Saleh


Background Antiepileptic drugs (AEDs) may affect calcium metabolism through several mechanisms. Much evidence has confirmed that carbamazepine and valproic acid, as the most widely used AEDs in epileptic children, leads to decreased serum calcium levels. This effect was suggested to be time and dose dependent. However, correlations between AEDs and calcium levels in Indonesian epileptic children have not been well studied.

Objective To investigate possible correlations between total calcium levels and durations of therapy as well as doses of carbamazepine and valproic acid.

Methods This analytical, cross-sectional study was performed from March to May 2015 in the Neuropediatric Outpatient Ward of Mohammad Hoesin Hospital, Palembang, South Sumatera. A total of 60 epileptic children taking carbamazepine and or valproic acid monotherapy were included and grouped accordingly. A single blood test was done for every participant to measure total serum calcium level. Correlation between daily dose or duration of AED with calcium level was assess using the Spearman-rho test.

Results The mean total serum calcium levels in the carbamazepine and valproic acid groups were 9.48 (SD 0.83) mg/dL and 9.58 (SD 0.63) mg/dL, respectively. There was a statistically significant moderate correlation between the duration of carbamazepine therapy and total calcium level (r = 0.36; P=0.001). The cut-off point for duration of therapy was 23 months. There were no significant correlations between total calcium level and mean daily carbamazepine dose, nor between total calcium level and duration and dose of valproic acid therapy.

Conclusion Longer duration of carbamazepine therapy is associated with low total serum calcium level, but carbamazepine dose is not. In addition, duration and dose of valproic acid are not associated with low total serum calcium level.

Article Details

How to Cite
Atmasari A, Dewi M, Aditiawati A, Saleh M. Duration and dose of antiepileptic drugs and serum calcium levels in children. PI [Internet]. 28Apr.2017 [cited 28Sep.2020];57(2):104-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1033
Received 2016-11-16
Accepted 2017-04-27
Published 2017-04-28


1. Pack AM. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3:91-5.
2. Nakken KO. Adverse metabolic effect of antiepileptic drug treatment. In: Foyaca-Sibat H, editor. Novel treatment of epilepsy. Shanghai: Intech; 2011. p. 83-94.
3. Guyton AC, Hall JE. Textbook of medical physiology. 9th ed. Philadelphia: W.B. Saunders Company; 1996. p. 1241-63.
4. Menon B, Harinarayan CV. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism – a longitudinal study. Seizure. 2010;19:153-8.
5. Shiva S, Barzgar M. Antiepileptic drugs effect on vitamin D status of epileptic children. Iran J Pediatr. 2007;17:525-30.
6. Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M. Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr. 2009;76:377-83.
7. Pratico AD, Pavone P, Scuderi MG, Li Volti G, Bernardini R, Cantarella G. Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report. Cases J. 2009;2:7394.
8. Engorn B, Flerlage J. Blood chemistries and body fluids. In: Engorn B, Flerlage J. The Harriet Land Handbook: a manual for pediatric house officer. 20th ed. Philadelphia: Saunders; 2015. p. 624-28.
9. Valsamis HA, Arora SK, Labban B, MacFarlene SI. Antiepileptic drugs and bone metabolism. Nutr Metab. 2006;3:36.
10. Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatric Neurology. 2010;43:320-4.  doi: 10.1016/j.pediatrneurol.2010.05.013.
11. Manzi P, Pizzoferrato L. UHT thermal processing of milk. In: Sun DW, editior. Thermal food processing: new technologies and quality issues. Boca Raton: CRC Press; 2006. p.316.